CHICAGO - Coronary CT angiography reveals similarities between coronary disease and cardiovascular risk among both men and women.
CHICAGO - Coronary computed tomography angiography (CCTA) revealed that mild coronary disease and cardiovascular risk is similar among both men and women, according to a study presented this week at RSNA 2013.
Researchers from St. Paul’s Hospital in Vancouver, Canada, undertook their study to determine whether men and women with the same extend of coronary artery disease (CAD) and similar risk profiles had the same prognoses.
"There is a tendency to think women's heart disease is very different than men's heart disease,” Jonathan Leipisc, MD, said in a release. “Our data show that once plaque accumulates in the coronary arteries, the prognosis is very similar between men and women." Leipisc is the director of medical imaging at the hospital.
For the study, the researchers identified 18,158 patients without known CAD and normal CCTA or who had nonobstructive disease from data obtained from the Coronary CT Angiography Evaluation For Clinical Outcomes: An International Multicenter (CONFIRM) Registry. The 8,808 women and 9,350 men were matched by cardiovascular risk factors and the extent of heart disease as determined by CCTA, resulting in a one-to-one cohort of 11,462 patients.
Follow-up was an average of 2.3 years. The results showed that major adverse cardiac events (MACE) occurred in 251 patients (0.6 percent annual event). Women were more likely to be dyslipidemic, hypertensive, diabetic, and have a family history of CAD, while men were more likely to have higher Framingham risk score. Nonobstructive CAD conferred a similar adverse risk of death or heart attack in both men and women. Conversely, the absence of plaque on CCTA conferred a good prognosis for both men and women.
"This analysis is exciting, because this has never been shown before," Leipsic said. "There's a prevailing belief that mild CAD puts women at greater risk for a major cardiac event compared to men with mild CAD. Our findings show this is just not true."
CT Study Reveals Key Indicators for Angiolymphatic Invasion in Non-Small Cell Lung Cancer
January 15th 2025In computed tomography (CT) scans for patients with solid non-small cell lung cancer (NSCLC) < 30 mm, emerging research suggests the lollipop sign is associated with a greater than fourfold likelihood of angiolymphatic invasion.
New CT and MRI Research Shows Link Between LR-M Lesions and Rapid Progression of Early-Stage HCC
January 2nd 2025Seventy percent of LR-M hepatocellular carcinoma (HCC) cases were associated with rapid growth in comparison to 12.5 percent of LR-4 HCCs and 28.5 percent of LR-4 HCCs, according to a new study.
The Reading Room: Artificial Intelligence: What RSNA 2020 Offered, and What 2021 Could Bring
December 5th 2020Nina Kottler, M.D., chief medical officer of AI at Radiology Partners, discusses, during RSNA 2020, what new developments the annual meeting provided about these technologies, sessions to access, and what to expect in the coming year.
Can AI Facilitate Single-Phase CT Acquisition for COPD Diagnosis and Staging?
December 12th 2024The authors of a new study found that deep learning assessment of single-phase CT scans provides comparable within-one stage accuracies to multiphase CT for detecting and staging chronic obstructive pulmonary disease (COPD).
Study Shows Merits of CTA-Derived Quantitative Flow Ratio in Predicting MACE
December 11th 2024For patients with suspected or known coronary artery disease (CAD) without percutaneous coronary intervention (PCI), researchers found that those with a normal CTA-derived quantitative flow ratio (CT-QFR) had a 22 percent higher MACE-free survival rate.